Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.47 |
| ▸ | PGK2 | P07205 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6765506 | 0.89 | ADORA3 (0.49) | ADORA3ADORA1KDM4EPKM | |
| SCHEMBL28894183 | 0.86 | ADORA3 (0.54) | ADORA3ADORA1KDM4EPKMSLC29A1 | |
| SCHEMBL28894185 | 0.86 | ADORA3 (0.54) | ADORA3ADORA1KDM4EPKMSLC29A1 | |
| SCHEMBL28403790 | 0.86 | ADORA2A (0.58) | ADORA3ADORA1 | |
| SCHEMBL29238707 | 0.85 | KDM4E (0.52) | ADORA3KDM4EPKMSLC29A1CYP2C19 | |
| SCHEMBL29238705 | 0.85 | KDM4E (0.52) | ADORA3KDM4EPKMSLC29A1CYP2C19 | |
| SCHEMBL29278767 | 0.84 | ADORA3 (0.59) | ADORA3ADORA1KDM4EPKMPGK1 | |
| SCHEMBL31490447 | 0.83 | KDM4E (0.54) | ADORA3ADORA1KDM4EPKM | |
| SCHEMBL1274809 | 0.83 | ADORA3 (0.51) | ADORA3ADORA1KDM4EPKMSLC29A1 | |
| SCHEMBL1274810 | 0.83 | ADORA3 (0.51) | ADORA3ADORA1KDM4EPKMSLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117413065-A | Constructs, methods and uses for the preparation of circular RNAs | 上海环码生物医药有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| CN-120158444-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-17 | — | — | CN | disclosed |
| CN-120129688-A | Efficient method for preparing highly purified 5' -capped oligonucleotides | 垂林克生物技术有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120129532-A | Stabilized lipid or lipid nanoparticle suspensions | 埃泽瑞斯公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-120082543-A | Negative selection method and system for purifying circular nucleic acid | 上海环码生物医药有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-119768533-A | Improved method for in vitro transcription | 阿克丘勒斯治疗公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119768517-A | Method and system for purifying circular nucleic acids | 上海环码生物医药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119656184-A | Targeted delivery of modified RNAs | 香港中文大学 | 2025-03-21 | — | — | CN | disclosed |
| CN-113423418-B | Treatment of cilia disease | 埃泽瑞斯公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-115176005-A | Compositions and methods for treating hemoglobinopathies | 诺华股份有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114404581-A | Cancer vaccine | 摩登纳特斯有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-108430456-B | Cancer vaccine | 摩登纳特斯有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-113840926-A | Method for preparing lipid-encapsulated RNA nanoparticles | 阿克丘勒斯治疗公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-113396219-A | Purification of mRNA by tangential flow filtration | 埃泽瑞斯公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-112805386-A | Plasmid containing a sequence encoding mRNA having a segmented poly (A) tail | 埃泽瑞斯公司 | 2021-05-14 | — | — | CN | disclosed |
| CN-112105733-A | Synthetic RIG-I like receptor agonists | 查美特制药公司 | 2020-12-18 | — | — | CN | disclosed |
| CN-111848712-A | End-capped nucleic acid molecules | 诺华股份有限公司 | 2020-10-30 | — | — | CN | disclosed |
| CN-111246854-A | Modified MRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof | 宾夕法尼亚大学理事会 | 2020-06-05 | — | — | CN | disclosed |
| CN-110891553-A | Method for producing liposome encapsulating RNA | 葛兰素史密丝克莱恩生物有限公司 | 2020-03-17 | — | — | CN | disclosed |